Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00778427 · ClinicalTrials.gov registry record · NA

Bioequivalence Study of Metformin Hydrochloride 1000mg Tablets Under Fasting Conditions

A NA study of Healthy, sponsored by Ranbaxy Laboratories Limited.

Completed
Registry status
NA
Development phase
32
Enrollment target
1
Study location

NCT00778427: Completed NA study of Healthy, sponsored by Ranbaxy Laboratories Limited.

NCT00778427 is a NA study of Healthy that has completed, run by Ranbaxy Laboratories Limited. The registered enrollment target is 32 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00778427, a NA study of Healthy, has completed, sponsored by Ranbaxy Laboratories Limited.

COMPLETED
Registry status
NA
Development phase
32 participants
Enrollment target
1
Study location

Study Summary

The objective of this study was to evaluate the relative bioavailability of the test formulation of metformin hydrochloride 1000 mg tablets with an already marketed reference formulation GLUCOPHAGE® (metformin hydrochloride) 1000 mg tablets (Bristol-Myers Squibb Company) under fasted conditions in healthy, male and female adult subjects.

Conditions Studied

Interventions

  • DRUG metformin hydrochloride 1000 mg tablets

Study Locations (1)

Nevada

  • NovumPharmaceutical Research Services - Las Vegas

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2006-02
Est. Completion 2006-04
Phase NA

Sponsor

Ranbaxy Laboratories Limited

44 total trials

What the Registry Record Tells You About NCT00778427

The ClinicalTrials.gov registry entry for NCT00778427 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (95% lower). The listed sponsor is Ranbaxy Laboratories Limited, which has 44 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which metformin hydrochloride 1000 mg tablets is the first listed.

NCT00778427 reports 1 study location spanning 1 distinct geographic area - top geographies include Nevada.

Frequently Asked Questions

What is clinical trial NCT00778427 about?

NCT00778427 is a clinical study titled "Bioequivalence Study of Metformin Hydrochloride 1000mg Tablets Under Fasting Conditions". The objective of this study was to evaluate the relative bioavailability of the test formulation of metformin hydrochloride 1000 mg tablets with an already marketed reference formulation GLUCOPHAGE® (metformin hydrochloride) 1000 mg tablets (Bristol-Myers Squibb Company) under fasted conditions in h...

What is the current status of trial NCT00778427?

This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2006-02. Estimated completion is 2006-04.

What conditions does trial NCT00778427 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT00778427?

The interventions under investigation include: metformin hydrochloride 1000 mg tablets (DRUG).

Who is sponsoring clinical trial NCT00778427?

This trial is sponsored by Ranbaxy Laboratories Limited, which has 44 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00778427 being conducted?

This trial has 1 study location across Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.